ConductScience.org, home

Gene · 1303

COL12A1: collagen type XII alpha 1 chain

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. COL12A1: collagen type XII alpha 1 chain. Genes, record 1303. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1303

On this page

Gene

Symbol
COL12A1
HGNC
Name
collagen type XII alpha 1 chain
HGNC
NCBI Gene ID
1303
NCBI Gene
HGNC ID
HGNC:2188
HGNC
Ensembl
ENSG00000111799
NCBI Gene
Aliases
BA209D8.1, BTHLM2, COL12A1L, DJ234P15.1, EDSMYP, UCMD2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q99715Collagen alpha-1(XII) chain3,0631Ensembl, GeneID, HGNC

Source UniProt

Patents32

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-195588Q99715Espacenet
EP 4640849 A22025-10-29800Q99715Espacenet
EP 4641201 A22025-10-295232Q99715Espacenet
JP 2025147176 A2025-10-063225Q99715Espacenet
JP 2025529142 A2025-09-045935Q99715Espacenet
US 12371689 B22025-07-295935Q99715Espacenet
JP 2025519096 A2025-06-24800Q99715Espacenet
JP 2025517969 A2025-06-125232Q99715Espacenet
JP 2025517970 A2025-06-125588Q99715Espacenet
JP 2025032204 A2025-03-1126621Q99715Espacenet

1 to 10 of 32

See all 32 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants834

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCOL12A1 papersNewest fiscal year
ZIANS003129Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies72025
P30CA008748Cancer Center Support Grant62025
P30CA091842Cancer Center Support Grant42025
P30ES010126UNC Center for Environmental Health and Susceptibility32025
U54GM104942West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health32025
ZICES102445Gene Expression and Microarrays32025
P20GM121322Tumor Microenvironment-TME CoBRE22025
P30AG066511Goizueta Alzheimer's Disease Research Center22025
P30AI094189The Johns Hopkins Center for AIDS Research (JHU CFAR)22025
P30AR075043University of Michigan Skin Biology and Diseases Resource-based Center22025

1 to 10 of 834Source NIH's project files

See all 834 nih grants

Papers1,356

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Alternative Splicing Constitutes a Transcription-independent Regulatory Layer in Replicative Senescence of Human Umbilical Cord Mesenchymal Stem Cells.Stem Cell Rev Rep202642742668PubTator, text miningPubMed
Histology-derived prediction of a stromal remodeling program in pancreatic ductal adenocarcinoma with transcriptomic and spatial validation.Transl Oncol202642526385PubTator, text miningPubMed
Naringin sensitizes nasopharyngeal carcinoma cells to paclitaxel by inducing AKR1C3 expression.J Int Med Res202642523162PubTator, text miningPubMed
Multi-Omics Analysis Reveals New Insights into Yak Lung Under High-Altitude Adaptation.Animals (Basel)202642353386PubTator, text miningPubMed
An epithelial mesenchymal transition associated gene signature stratifies risk of ulcerative colitis associated colorectal cancer.Discov Oncol202642319552PubTator, text miningPubMed
RNA binding protein YWHAZ mediates specific mRNA translation and regulates cell proliferation and apoptosis in diabetic foot ulcer.Front Med (Lausanne)202642180716PubTator, text miningPubMed
COL12A1 rs970547 Polymorphism Predisposes Anterior Cruciate Ligament Injury by Inducing ER Stress and Impairing Fibroblast Function.Adv Biol (Weinh)202642076899PubTator, text miningPubMed
Comparative omics reveals conserved extracellular matrix signatures during mammary tumor progression.Front Oncol202641952687PubTator, text miningPubMed
Gene Expression Alterations Associated With Resveratrol-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Osteosarcoma Cancer Cells.J Cell Mol Med202641937498PubTator, text miningPubMed
Proteomic analysis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis.Sci Rep202641896629PubTator, text miningPubMed

1 to 10 of 1,356

See all 1,356 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/1303

GET https://conductscience.org/api/genes/v1/1303/patents?page=2